On Mar. 15, 2020, CureVac announced that internal efforts will be focused on the development of a coronavirus vaccine with the goal to reach, help and to protect people and patients worldwide.

CureVac saw mRNA as one of the most potent molecules to provide fast and efficient solutions in outbreak scenarios, such like the Coronavirus.